THE ADDED VALUE OF HEALTH-RELATED QUALITY OF LIFE (HRQoL) AS A PROGNOSTIC INDICATOR OF OVERALL SURVIVAL AND PROGRESSION FREE SURVIVAL IN GLIOMA PATIENTS: A META-ANALYSIS BASED ON INDIVIDUAL PATIENT DATA FROM RANDOMIZED CONTROLLED TRIALS

Author(s):
Coomans, M.; Dirven, L.; Aaronson, N.; Baumert, B.G.; Bent, M. van den; Bottomley, A.; Brandes, A.; Chinot, O.; Coens, C.; Gorlia, T.; Herrlinger, U.; Keime-Guibert, F.; Malmstrom, A.; Martinelli, F.; Stupp, R.; Talacchi, A.; Wick, W.; Reijneveld, J.C.; Taphoorn, M.J.B.
Published
2017
Publication type
Article / Letter to editor
Date issued
2017-11-30
Language
English
Is part of
Neuro-Oncology (2017), Vol. 19, p. 207-207
hdl
1887/88287